AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
End points in studies on the prevention of deep vein thrombosis
Authors: Sonaglia, F Rossi, R Agnelli, G
Citation: F. Sonaglia et al., End points in studies on the prevention of deep vein thrombosis, SEM THROMB, 27(1), 2001, pp. 41-46
Risk factors for adverse short-term outcome in patients with pulmonary embolism
Authors: Becattini, C Agnelli, G
Citation: C. Becattini et G. Agnelli, Risk factors for adverse short-term outcome in patients with pulmonary embolism, THROMB RES, 103(6), 2001, pp. V239-V244
Clinical and economic aspects of managing venous thromboembolism in the outpatient setting
Authors: Agnelli, G Becattini, C
Citation: G. Agnelli et C. Becattini, Clinical and economic aspects of managing venous thromboembolism in the outpatient setting, SEM HEMATOL, 38(2), 2001, pp. 58-66
Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis.
Authors: Agnelli, G Prandoni, P Santamaria, MG Bagatella, P Iorio, A Bazzan, M Moia, M Guazzaloca, G Bertoldi, A Tomasi, C Scannapieco, G Ageno, W Ascani, A Villalta, S Frulla, M Mosena, L Girolami, A Vaccarino, A Alatri, A Palareti, G Marchesi, M Ambrosio, GB Parisi, R Doria, S Steidl, L Ambrosini, F Silingardi, M Ghirarduzzi, A Iori, I
Citation: G. Agnelli et al., Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis., N ENG J MED, 345(3), 2001, pp. 165-169
Antithrombotic therapy for venous thromboembolic disease
Authors: Hyers, TM Agnelli, G Hull, RD Morris, TA Samama, M Tapson, V Weg, JG
Citation: Tm. Hyers et al., Antithrombotic therapy for venous thromboembolic disease, CHEST, 119(1), 2001, pp. 176S-193S
Intravenous thrombolysis in acute myocardial infarction
Authors: Ohman, EM Harrington, RA Cannon, CP Agnelli, G Cairns, JA Kennedy, JW
Citation: Em. Ohman et al., Intravenous thrombolysis in acute myocardial infarction, CHEST, 119(1), 2001, pp. 253S-277S
Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement
Authors: Lee, A Agnelli, G Buller, H Ginsberg, J Heit, J Rote, W Vlasuk, G Costantini, L Julian, J Comp, P van der Meer, J Piovella, F Raskob, G Gent, M
Citation: A. Lee et al., Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement, CIRCULATION, 104(1), 2001, pp. 74-78
Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: A multinational registry of patients hospitalized with acute coronary syndromes
Authors: Agnelli, G Avezum, A Brieger, D Budaj, A Cannon, CP Goldberg, RJ Goodman, S Gulba, DC Granger, C Kennelly, BM Gurfinkel, E Lopez-Sendon, J Klein, W Montalescot, G Van de Werf, F
Citation: G. Agnelli et al., Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: A multinational registry of patients hospitalized with acute coronary syndromes, AM HEART J, 141(2), 2001, pp. 190-199
Low-molecular-weight heparins in the management of unstable angina
Authors: Agnelli, G Sonaglia, F
Citation: G. Agnelli et F. Sonaglia, Low-molecular-weight heparins in the management of unstable angina, HAEMOSTASIS, 30, 2000, pp. 158-167
The rationale for long-term prophylaxis of venous thromboembolism
Authors: Agnelli, G Mancini, GB Biagini, D
Citation: G. Agnelli et al., The rationale for long-term prophylaxis of venous thromboembolism, ORTHOPEDICS, 23(6), 2000, pp. S643-S646
Prevention of venous thromboembolism
Authors: Agnelli, G Sonaglia, F
Citation: G. Agnelli et F. Sonaglia, Prevention of venous thromboembolism, THROMB RES, 97(1), 2000, pp. V49-V62
Treatment of proximal deep vein thrombosis with a novel synthetic compound(SR90107A/ORG31540) with pure anti-factor Xa activity - A phase II evaluation
Authors: Buller, HR Cariou, R Gallus, A Gent, M Ginsberg, J Prins, MH Lensing, A Levi, M Nurmohammed, N Hirsh, J Roberts, R ten Cate, JW Decousus, H Mismetti, P Buchmuller, A Charlet, V Viallon, A van der Meer, J Meinardi, JR Meijer, K Piovella, F Barone, M Beltrametti, C Serafini, S Kraaijenhagen, RA Koopman, MMW Jagt, HHT Muller, MBR Kooy, MV Nauta, S Gallus, AS Coghlan, D Rich, C Prandoni, P Scudeller, A Scarano, L Girolami, A Baker, R Tan, E Cooney, J Eikelboom, J Ninet, J Dolmazon, C Madoux, MHG Coppere, B Nenci, GG Agnelli, G Falcinelli, F Morini, M d'Angelo, A Crippa, L d'Angelo, SV Chong, B Chestreman, C Malvin, J Eisbacher, M MacGillavry, MR Brandjes, DPM Beaumont, JFM Olmos, RAV Turpie, AGG Johnson, J Nowacki, B Anderson, D Pleasance, S Mitchell, M Ockelford, P Bennett, A Jones, R Porteous, F Weitz, J Kearon, C Simonneau, G Parent, F Douketis, J Schnurr, T Hainaut, P Petit, B Jaumotte, C Huisman, MV van Poelgeest, MIE Meinders, AE van Oostayen, JA Beer, J Lugli, A Pederiva, S Ginsberg, J Brill-Edwards, P Stevens, P Bassand, JP Seronde, MF Kassis, J Fortin, M Faivre, R Petiteau, PY Verhaeghe, R Wells, P Lewandowski, B Touchie, D Banga, JD Hartmann, IJC Zeguers, VJM Desjardins, L Villeneuve, J Cote, J Bounameaux, H Cirafici, P Demers, C van der Heul, C Kruip, M
Citation: Hr. Buller et al., Treatment of proximal deep vein thrombosis with a novel synthetic compound(SR90107A/ORG31540) with pure anti-factor Xa activity - A phase II evaluation, CIRCULATION, 102(22), 2000, pp. 2726-2731
Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction
Authors: Grifoni, S Olivotto, I Cecchini, P Pieralli, F Camaiti, A Santoro, G Conti, A Agnelli, G Berni, G
Citation: S. Grifoni et al., Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction, CIRCULATION, 101(24), 2000, pp. 2817-2822
Tow-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery - A meta-analysis
Authors: Iorio, A Agnelli, G
Citation: A. Iorio et G. Agnelli, Tow-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery - A meta-analysis, ARCH IN MED, 160(15), 2000, pp. 2327-2332
Clinical status of direct thrombin inhibitors
Authors: Agnelli, G Sonaglia, F
Citation: G. Agnelli et F. Sonaglia, Clinical status of direct thrombin inhibitors, CR R ONC H, 31(2), 1999, pp. 97-117
Pre-operative plasma levels of soluble fibrin polymers correlate with the development of deep vein thrombosis after elective neurosurgery
Authors: Sonaglia, F Agnelli, G Baroni, M Severi, P Quintavalla, R D'Angelo, SV
Citation: F. Sonaglia et al., Pre-operative plasma levels of soluble fibrin polymers correlate with the development of deep vein thrombosis after elective neurosurgery, BL COAG FIB, 10(8), 1999, pp. 459-463
Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation
Authors: Ascani, A Iorio, A Agnelli, G
Citation: A. Ascani et al., Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation, BL COAG FIB, 10(5), 1999, pp. 291-295
Building effective prophylaxis of deep vein thrombosis in the outpatient setting
Authors: Agnelli, G Taliani, MR Verso, M
Citation: G. Agnelli et al., Building effective prophylaxis of deep vein thrombosis in the outpatient setting, BL COAG FIB, 10, 1999, pp. S29-S35
Workshop II: The future of prolonged thromboprophylaxis
Authors: Haas, S Agnelli, G Arcelus, JI Davidson, BL Lassen, MR Planes, A
Citation: S. Haas et al., Workshop II: The future of prolonged thromboprophylaxis, BL COAG FIB, 10, 1999, pp. S103-S106
Local versus central assessment of venographies in a multicenter trial on the prevention of deep vein thrombosis in neurosurgery
Authors: Rossi, R Agnelli, G Taborelli, P Fioroni, C Zerbi, D Pattacini, P Giugni, E Bagatella, P Vaccarino, A
Citation: R. Rossi et al., Local versus central assessment of venographies in a multicenter trial on the prevention of deep vein thrombosis in neurosurgery, THROMB HAEM, 82(5), 1999, pp. 1399-1402
Prevention of venous thromboembolism after neurosurgery
Authors: Agnelli, G
Citation: G. Agnelli, Prevention of venous thromboembolism after neurosurgery, THROMB HAEM, 82(2), 1999, pp. 925-930
Dermatan sulphate for the prevention of postoperative venous thromboembolism in patients with cancer
Authors: Di Carlo, V Agnelli, G Prandoni, P Coccheri, S Gensini, GF Gianese, F Mannucci, PM
Citation: V. Di Carlo et al., Dermatan sulphate for the prevention of postoperative venous thromboembolism in patients with cancer, THROMB HAEM, 82(1), 1999, pp. 30-34
Optimizing therapy with oral anticoagulants: Risk analysis and socio-economic aspects - Preface
Authors: Morsdorf, S Agnelli, G Preston, FE Wenzel, E
Citation: S. Morsdorf et al., Optimizing therapy with oral anticoagulants: Risk analysis and socio-economic aspects - Preface, SEM THROMB, 25(1), 1999, pp. 1-3
Management of oral anticoagulant therapy in Italy
Authors: Berrettini, M Agnelli, G
Citation: M. Berrettini et G. Agnelli, Management of oral anticoagulant therapy in Italy, SEM THROMB, 25(1), 1999, pp. 27-31
Untitled
Authors: Agnelli, G
Citation: G. Agnelli, Untitled, THROMB RES, 95(3), 1999, pp. V3-V3
Risultati: 1-25 | 26-26